FAM
IART icon

Fred Alger Management’s Integra LifeSciences IART Stock Holding History

Fred Alger Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16,000
Closed -$638K – 514
2016
Q2 		$638K Sell
16,000
-8,800
-35% -$317K ﹤0.01% 359
2016
Q1 		$835K Buy
24,800
+8,800
+55% +$274K ﹤0.01% 388
2015
Q4 		$542K Buy
+16,000
New +$500K ﹤0.01% 429

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fred Alger Management's IART Position: Q3 2016 in Review

Fred Alger Management sold out of Integra LifeSciences (IART) in Q3 2016, closing a stake of 16,000 shares — an estimated $638K sold.

Fred Alger Management first reported a position in IART in Q4 2015 and held it in 3 quarters. The position peaked at $835K in Q1 2016. 234 funds tracked by Wall St. Rank hold IART as of Q3 2016.

  • Fred Alger Management reported no remaining Integra LifeSciences position as of Q3 2016 after selling out during the quarter.
  • Fred Alger Management sold 16,000 Integra LifeSciences shares in Q3 2016, an estimated $638K.
  • Fred Alger Management first reported a position in Integra LifeSciences in Q4 2015 and held it in 3 quarters.
  • Fred Alger Management's Integra LifeSciences position peaked at $835K in Q1 2016.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2016.

Based on Fred Alger Management's 13F filing for Q3 2016, filed 14 Nov 2016.